| payload |
{"created_at":"2026-04-10T03:04:31.796 {"created_at":"2026-04-10T03:04:31.796915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:1b9ed074b304061d","evidence_event_ids":["evt_e1ce66e256f5"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","article_chars":2126,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c9e78c007974d0fb","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:19:53.495207+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt","source_event_id":"evt_e1ce66e256f5","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"c4ea3f19ffee98cd","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-09","2026-04-08","2026-01-09","2026-01-13","2026-02-12","2026-02-23"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"brokerage_or_signatory"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only the current Form 144 filing content is shown.","The filing\u2019s purpose/estimated aggregate sale amount is not explicitly summarized; only line-item quantities and some dollar figures appear, but totals are not clearly stated.","No explicit stock ticker/symbol is provided in the extracted text (only \u201cNASDAQ\u201d appears alongside \u201cCommon\u201d).","The exact total number of shares and total sale proceeds are not explicitly stated as a single figure in the provided text; only individual line items are visible."],"key_facts":["SEC accession number: 0001959173-26-002853.","Form type: 144.","Filed as of date: 2026-04-09; date as of change: 2026-04-09.","Subject company: Twist Bioscience Corp (CIK 0001581280; SIC 2836).","Reporting owner: Adam Laponis (CIK 0001827198).","The filing references common stock and includes a statement: \u201cSale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.\u201d","The filing includes multiple line items with quantities and dates (e.g., 2597 shares on 04/08/2026; 2738 shares on 01/09/2026; 3000 shares on 01/13/2026; 7000 shares on 02/12/2026; 2085 shares on 02/23/2026).","The document is signed: \u201c/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adam Laponis.\u201d"],"numeric_claims":[{"label":"Total shares shown (sum of listed quantities)","value":"(Uncertain: quantities listed include 2597, 2738, 3000, 7000, 2085; sum not explicitly stated in text)"}],"primary_claim":"On 2026-04-09, Twist Bioscience Corp filed SEC Form 144 (accession 0001959173-26-002853) for common stock sales by Adam Laponis, including tax-related proceeds from vested equity award settlement.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Twist Bioscience Corp filed a Form 144 on 2026-04-09 related to sales of common stock by reporting owner Adam Laponis. The filing indicates the sales relate to restricted stock vesting and includes an amount for taxes upon settlement of a vested equity award.","topics":["SEC Form 144","restricted stock vesting","common stock sale","tax obligation","insider/affiliate sale disclosure"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260409","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 144","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002853.txt"}}... |